Shopping Cart 0
Cart Subtotal
USD 0

Global Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3100

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4800

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6500

Details

Global autoimmune disease diagnostics market will reach USD 10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.

Highlighted with 87 tables and 103 figures, this 188-page report Global Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Assay Kits & Consumables

Analyzers & Instruments

Based on Test Type, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Autoantibodies and Immunologic Tests

o Antinuclear Antibody Tests

o Anti-cyclic Citrullinated Peptide

o Enzyme-Linked Immunosorbent Assay (ELISA)

o Rheumatoid Factor

o Thyroid Antibody Tests

o Other Autoantibodies and Immunologic Tests

Inflammatory Marker Tests

o C-Reactive Protein (CRP)

o Erythrocyte Sedimentation Rate (ESR)

o Other Inflammatory Marker Tests

Routine Laboratory Tests

o Urinalysis

o Complete Blood Count (CBC) Tests

o Other Routine Laboratory Tests

Other Test Types

Based on Disease Type, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Systemic Autoimmune Disease

o Rheumatoid Arthritis

o Systemic Lupus Erythematosus (SLE)

o Psoriasis/Psoriatic Arthritis

o Other Systemic Autoimmune Diseases

Localized Autoimmune Disease

o Thyroiditis

o Multiple Sclerosis

o Inflammatory Bowel Disease

o Type 1 Diabetes

o Other Localized Autoimmune Diseases

Based on Gender, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Female Patients

Male Patients

Based on Age, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

< 44

44 - 64

> 64

Based on End User, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Hospitals

Clinics

Diagnostic Labs

Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

North America (U.S., Canada, and Mexico)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

South America (Brazil, Chile, Argentina, Rest of South America)

MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Table Of Content

Scope

1 Introduction 11

1.1 Industry Definition and Research Scope 11

1.1.1 Industry Definition 11

1.1.2 Research Scope 12

1.2 Research Methodology 15

1.2.1 Overview of Market Research Methodology 15

1.2.2 Market Assumption 16

1.2.3 Secondary Data 16

1.2.4 Primary Data 16

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.1.1 Impact of COVID-19 on World Economy 24

2.1.2 Impact of COVID-19 on the Market 26

2.2 Major Growth Drivers 28

2.3 Market Restraints and Challenges 33

2.4 Emerging Opportunities and Market Trends 36

2.5 Porter's Fiver Forces Analysis 40

3 Segmentation of Global Market by Product 45

3.1 Market Overview by Product 45

3.2 Assay Kits & Consumables 47

3.3 Analyzers & Instruments 48

4 Segmentation of Global Market by Test Type 49

4.1 Market Overview by Test Type 49

4.2 Autoantibodies and Immunologic Tests 51

4.2.1 Antinuclear Antibody Tests 53

4.2.2 Anti-cyclic Citrullinated Peptide 54

4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 55

4.2.4 Rheumatoid Factor 56

4.2.5 Thyroid Antibody Tests 57

4.2.6 Other Autoantibodies and Immunologic Tests 58

4.3 Inflammatory Marker Tests 59

4.3.1 C-Reactive Protein (CRP) 61

4.3.2 Erythrocyte Sedimentation Rate (ESR) 62

4.3.3 Other Inflammatory Marker Tests 63

4.4 Routine Laboratory Tests 64

4.4.1 Urinalysis 66

4.4.2 Complete Blood Count (CBC) Tests 67

4.4.3 Other Routine Laboratory Tests 68

4.5 Other Test Types 69

5 Segmentation of Global Market by Disease Type 70

5.1 Market Overview by Disease Type 70

5.2 Systemic Autoimmune Disease 72

5.2.1 Rheumatoid Arthritis 74

5.2.2 Systemic Lupus Erythematosus (SLE) 75

5.2.3 Psoriasis/Psoriatic Arthritis 76

5.2.4 Other Systemic Autoimmune Diseases 77

5.3 Localized Autoimmune Disease 78

5.3.1 Thyroiditis 80

5.3.2 Multiple Sclerosis 81

5.3.3 Inflammatory Bowel Disease 82

5.3.4 Type 1 Diabetes 83

5.3.5 Other Localized Autoimmune Diseases 84

6 Segmentation of Global Market by Gender 85

6.1 Market Overview by Gender 85

6.2 Female Patients 87

6.3 Male Patients 88

7 Segmentation of Global Market by Age 89

7.1 Market Overview by Age 89

7.2 < 44 91

7.3 44 - 64 92

7.4 > 64 93

8 Segmentation of Global Market by End User 94

8.1 Market Overview by End User 94

8.2 Hospitals 96

8.3 Clinics 97

8.4 Diagnostic Labs 98

8.5 Other End Users 99

9 Segmentation of Global Market by Region 100

9.1 Geographic Market Overview 2021-2031 100

9.2 North America Market 2021-2031 by Country 104

9.2.1 Overview of North America Market 104

9.2.2 U.S. 108

9.2.3 Canada 111

9.2.4 Mexico 113

9.3 European Market 2021-2031 by Country 115

9.3.1 Overview of European Market 115

9.3.2 Germany 119

9.3.3 U.K. 121

9.3.4 France 123

9.3.5 Spain 125

9.3.6 Italy 127

9.3.7 Russia 129

9.3.8 Rest of European Market 131

9.4 Asia-Pacific Market 2021-2031 by Country 133

9.4.1 Overview of Asia-Pacific Market 133

9.4.2 Japan 137

9.4.3 China 140

9.4.4 Australia 142

9.4.5 India 144

9.4.6 South Korea 146

9.4.7 Rest of APAC Region 148

9.5 South America Market 2021-2031 by Country 150

9.5.1 Argentina 153

9.5.2 Brazil 155

9.5.3 Chile 157

9.5.4 Rest of South America Market 159

9.6 MEA Market 2021-2031 by Country 160

9.6.1 UAE 163

9.6.2 Saudi Arabia 165

9.6.3 South Africa 167

9.6.4 Other National Markets 169

10 Competitive Landscape 170

10.1 Overview of Key Vendors 170

10.2 New Product Launch, Partnership, Investment, and M&A 173

10.3 Company Profiles 174

Abbott Laboratories 174

Beckman Coulter, Inc. 176

Biomerieux SA 177

Bio-rad Laboratories Inc. 178

F. Hoffmann-la Roche Ltd. 179

Hemagen Diagnostics Inc. 180

Myriad Genetics Inc. 181

PerkinElmer Inc. (Euroimmun AG) 182

Quest Diagnostics Inc. 183

Siemens Healthineers Inc. 184

Thermo Fisher Scientific Inc. 185

Trinity Biotech PLC 186

Werfen Company (Inova Diagnostics Inc.) 187

RELATED REPORTS 188


List Of Figure

List of Figures:

Figure 1. Research Method Flow Chart 15

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18

Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20

Figure 4. Global Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 23

Figure 5. Impact of COVID-19 on Business 26

Figure 6. Primary Drivers and Impact Factors of Global Autoimmune Disease Diagnostics Market 28

Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31

Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 31

Figure 9. Primary Restraints and Impact Factors of Global Autoimmune Disease Diagnostics Market 33

Figure 10. Investment Opportunity Analysis 37

Figure 11. Porter's Fiver Forces Analysis of Global Autoimmune Disease Diagnostics Market 40

Figure 12. Breakdown of Global Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 46

Figure 13. Global Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 46

Figure 14. Global Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, USD mn 47

Figure 15. Global Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, USD mn 48

Figure 16. Breakdown of Global Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 50

Figure 17. Global Addressable Market Cap in 2022-2031 by Test Type, Value (USD mn) and Share (%) 50

Figure 18. Global Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, USD mn 51

Figure 19. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, USD mn 53

Figure 20. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, USD mn 54

Figure 21. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, USD mn 55

Figure 22. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, USD mn 56

Figure 23. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, USD mn 57

Figure 24. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, USD mn 58

Figure 25. Global Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, USD mn 59

Figure 26. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, USD mn 61

Figure 27. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, USD mn 62

Figure 28. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, USD mn 63

Figure 29. Global Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, USD mn 64

Figure 30. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, USD mn 66

Figure 31. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, USD mn 67

Figure 32. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, USD mn 68

Figure 33. Global Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, USD mn 69

Figure 34. Breakdown of Global Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 71

Figure 35. Global Addressable Market Cap in 2022-2031 by Disease Type, Value (USD mn) and Share (%) 71

Figure 36. Global Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, USD mn 72

Figure 37. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, USD mn 74

Figure 38. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, USD mn 75

Figure 39. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, USD mn 76

Figure 40. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, USD mn 77

Figure 41. Global Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, USD mn 78

Figure 42. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, USD mn 80

Figure 43. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, USD mn 81

Figure 44. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, USD mn 82

Figure 45. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, USD mn 83

Figure 46. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, USD mn 84

Figure 47. Breakdown of Global Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 86

Figure 48. Global Addressable Market Cap in 2022-2031 by Gender, Value (USD mn) and Share (%) 86

Figure 49. Global Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, USD mn 87

Figure 50. Global Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, USD mn 88

Figure 51. Breakdown of Global Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 90

Figure 52. Global Addressable Market Cap in 2022-2031 by Age, Value (USD mn) and Share (%) 90

Figure 53. Global Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, USD mn 91

Figure 54. Global Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, USD mn 92

Figure 55. Global Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, USD mn 93

Figure 56. Breakdown of Global Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 94

Figure 57. Global Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 95

Figure 58. Global Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, USD mn 96

Figure 59. Global Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, USD mn 97

Figure 60. Global Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, USD mn 98

Figure 61. Global Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 99

Figure 62. Global Market Snapshot by Region 100

Figure 63. Geographic Spread of Worldwide Autoimmune Disease Diagnostics Market, 2021-2031, % of Sales Revenue 101

Figure 64. Global Addressable Market Cap in 2022-2031 by Region, Value (USD mn) and Share (%) 102

Figure 65. North American Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 105

Figure 66. Breakdown of North America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 106

Figure 67. Contribution to North America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 107

Figure 68. U.S. Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 109

Figure 69. Canada Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 111

Figure 70. Autoimmune Disease Diagnostics Market in Mexico, 2021-2031, USD mn 113

Figure 71. European Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 116

Figure 72. Breakdown of European Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 117

Figure 73. Contribution to Europe 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 118

Figure 74. Autoimmune Disease Diagnostics Market in Germany, 2021-2031, USD mn 119

Figure 75. Autoimmune Disease Diagnostics Market in U.K., 2021-2031, USD mn 121

Figure 76. Autoimmune Disease Diagnostics Market in France, 2021-2031, USD mn 123

Figure 77. Autoimmune Disease Diagnostics Market in Spain, 2021-2031, USD mn 125

Figure 78. Autoimmune Disease Diagnostics Market in Italy, 2021-2031, USD mn 127

Figure 79. Autoimmune Disease Diagnostics Market in Russia, 2021-2031, USD mn 129

Figure 80. Autoimmune Disease Diagnostics Market in Rest of Europe, 2021-2031, USD mn 131

Figure 81. Asia-Pacific Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 134

Figure 82. Breakdown of APAC Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 134

Figure 83. Contribution to APAC 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 136

Figure 84. Autoimmune Disease Diagnostics Market in Japan, 2021-2031, USD mn 138

Figure 85. Autoimmune Disease Diagnostics Market in China, 2021-2031, USD mn 140

Figure 86. Autoimmune Disease Diagnostics Market in Australia, 2021-2031, USD mn 142

Figure 87. Autoimmune Disease Diagnostics Market in India, 2021-2031, USD mn 144

Figure 88. Autoimmune Disease Diagnostics Market in South Korea, 2021-2031, USD mn 146

Figure 89. Autoimmune Disease Diagnostics Market in Rest of APAC, 2021-2031, USD mn 148

Figure 90. South America Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 151

Figure 91. Breakdown of South America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 151

Figure 92. Contribution to South America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 152

Figure 93. Autoimmune Disease Diagnostics Market in Argentina, 2021-2031, USD mn 153

Figure 94. Autoimmune Disease Diagnostics Market in Brazil, 2021-2031, USD mn 155

Figure 95. Autoimmune Disease Diagnostics Market in Chile, 2021-2031, USD mn 157

Figure 96. Autoimmune Disease Diagnostics Market in Rest of South America, 2021-2031, USD mn 159

Figure 97. Autoimmune Disease Diagnostics Market in Middle East and Africa (MEA), 2021-2031, USD mn 161

Figure 98. Breakdown of MEA Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 161

Figure 99. Contribution to MEA 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 162

Figure 100. Autoimmune Disease Diagnostics Market in UAE, 2021-2031, USD mn 163

Figure 101. Autoimmune Disease Diagnostics Market in Saudi Arabia, 2021-2031, USD mn 165

Figure 102. Autoimmune Disease Diagnostics Market in South Africa, 2021-2031, USD mn 167

Figure 103. Growth Stage of Global Autoimmune Disease Diagnostics Industry over the Forecast Period 170


List Of Table

List of Tables:

Table 1. Snapshot of Global Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 21

Table 2. World Economic Outlook, 2021-2031 25

Table 3. World Health Spending by Region, USD bn, 2013-2020 32

Table 4. Main Product Trends and Market Opportunities in Global Autoimmune Disease Diagnostics Market 36

Table 5. Global Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 45

Table 6. Global Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, USD mn 49

Table 7. Global Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, USD mn 52

Table 8. Global Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, USD mn 60

Table 9. Global Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, USD mn 65

Table 10. Global Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 70

Table 11. Global Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, USD mn 73

Table 12. Global Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, USD mn 79

Table 13. Global Autoimmune Disease Diagnostics Market by Gender, 2021-2031, USD mn 85

Table 14. Global Autoimmune Disease Diagnostics Market by Age, 2021-2031, USD mn 89

Table 15. Global Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 94

Table 16. Global Autoimmune Disease Diagnostics Market by Region, 2021-2031, USD mn 101

Table 17. Leading National Autoimmune Disease Diagnostics Market, 2021 and 2031, USD mn 103

Table 18. North America Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 106

Table 19. U.S. Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 110

Table 20. U.S. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 110

Table 21. U.S. Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 110

Table 22. Canada Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 112

Table 23. Canada Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 112

Table 24. Canada Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 112

Table 25. Mexico Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 114

Table 26. Mexico Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 114

Table 27. Mexico Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 114

Table 28. Europe Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 118

Table 29. Germany Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 120

Table 30. Germany Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 120

Table 31. Germany Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 120

Table 32. U.K. Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 122

Table 33. U.K. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 122

Table 34. U.K. Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 122

Table 35. France Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 124

Table 36. France Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 124

Table 37. France Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 124

Table 38. Spain Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 126

Table 39. Spain Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 126

Table 40. Spain Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 126

Table 41. Italy Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 128

Table 42. Italy Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 128

Table 43. Italy Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 128

Table 44. Russia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 130

Table 45. Russia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 130

Table 46. Russia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 130

Table 47. Autoimmune Disease Diagnostics Market in Rest of Europe by Country, 2021-2031, USD mn 132

Table 48. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 135

Table 49. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 139

Table 50. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 139

Table 51. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 139

Table 52. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 141

Table 53. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 141

Table 54. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 141

Table 55. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 143

Table 56. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 143

Table 57. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 143

Table 58. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 145

Table 59. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 145

Table 60. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 145

Table 61. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 147

Table 62. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 147

Table 63. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 147

Table 64. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, USD mn 149

Table 65. South America Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 152

Table 66. Argentina Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 154

Table 67. Argentina Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 154

Table 68. Argentina Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 154

Table 69. Brazil Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 156

Table 70. Brazil Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 156

Table 71. Brazil Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 156

Table 72. Chile Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 158

Table 73. Chile Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 158

Table 74. Chile Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 158

Table 75. MEA Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 162

Table 76. UAE Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 164

Table 77. UAE Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 164

Table 78. UAE Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 164

Table 79. Saudi Arabia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 166

Table 80. Saudi Arabia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 166

Table 81. Saudi Arabia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 166

Table 82. South Africa Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 168

Table 83. South Africa Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 168

Table 84. South Africa Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 168

Table 85. Abbott Laboratories: Company Snapshot 174

Table 86. Abbott Laboratories: Business Segmentation 175

Table 87. Abbott Laboratories: Product Portfolio 175

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Company Profile

Company Profile Title

Global autoimmune disease diagnostics market will reach USD 10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.

Highlighted with 87 tables and 103 figures, this 188-page report Global Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Assay Kits & Consumables

Analyzers & Instruments

Based on Test Type, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Autoantibodies and Immunologic Tests

o Antinuclear Antibody Tests

o Anti-cyclic Citrullinated Peptide

o Enzyme-Linked Immunosorbent Assay (ELISA)

o Rheumatoid Factor

o Thyroid Antibody Tests

o Other Autoantibodies and Immunologic Tests

Inflammatory Marker Tests

o C-Reactive Protein (CRP)

o Erythrocyte Sedimentation Rate (ESR)

o Other Inflammatory Marker Tests

Routine Laboratory Tests

o Urinalysis

o Complete Blood Count (CBC) Tests

o Other Routine Laboratory Tests

Other Test Types

Based on Disease Type, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Systemic Autoimmune Disease

o Rheumatoid Arthritis

o Systemic Lupus Erythematosus (SLE)

o Psoriasis/Psoriatic Arthritis

o Other Systemic Autoimmune Diseases

Localized Autoimmune Disease

o Thyroiditis

o Multiple Sclerosis

o Inflammatory Bowel Disease

o Type 1 Diabetes

o Other Localized Autoimmune Diseases

Based on Gender, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Female Patients

Male Patients

Based on Age, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

< 44

44 - 64

> 64

Based on End User, the global market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Hospitals

Clinics

Diagnostic Labs

Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

North America (U.S., Canada, and Mexico)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

South America (Brazil, Chile, Argentina, Rest of South America)

MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Scope

1 Introduction 11

1.1 Industry Definition and Research Scope 11

1.1.1 Industry Definition 11

1.1.2 Research Scope 12

1.2 Research Methodology 15

1.2.1 Overview of Market Research Methodology 15

1.2.2 Market Assumption 16

1.2.3 Secondary Data 16

1.2.4 Primary Data 16

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.1.1 Impact of COVID-19 on World Economy 24

2.1.2 Impact of COVID-19 on the Market 26

2.2 Major Growth Drivers 28

2.3 Market Restraints and Challenges 33

2.4 Emerging Opportunities and Market Trends 36

2.5 Porter's Fiver Forces Analysis 40

3 Segmentation of Global Market by Product 45

3.1 Market Overview by Product 45

3.2 Assay Kits & Consumables 47

3.3 Analyzers & Instruments 48

4 Segmentation of Global Market by Test Type 49

4.1 Market Overview by Test Type 49

4.2 Autoantibodies and Immunologic Tests 51

4.2.1 Antinuclear Antibody Tests 53

4.2.2 Anti-cyclic Citrullinated Peptide 54

4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 55

4.2.4 Rheumatoid Factor 56

4.2.5 Thyroid Antibody Tests 57

4.2.6 Other Autoantibodies and Immunologic Tests 58

4.3 Inflammatory Marker Tests 59

4.3.1 C-Reactive Protein (CRP) 61

4.3.2 Erythrocyte Sedimentation Rate (ESR) 62

4.3.3 Other Inflammatory Marker Tests 63

4.4 Routine Laboratory Tests 64

4.4.1 Urinalysis 66

4.4.2 Complete Blood Count (CBC) Tests 67

4.4.3 Other Routine Laboratory Tests 68

4.5 Other Test Types 69

5 Segmentation of Global Market by Disease Type 70

5.1 Market Overview by Disease Type 70

5.2 Systemic Autoimmune Disease 72

5.2.1 Rheumatoid Arthritis 74

5.2.2 Systemic Lupus Erythematosus (SLE) 75

5.2.3 Psoriasis/Psoriatic Arthritis 76

5.2.4 Other Systemic Autoimmune Diseases 77

5.3 Localized Autoimmune Disease 78

5.3.1 Thyroiditis 80

5.3.2 Multiple Sclerosis 81

5.3.3 Inflammatory Bowel Disease 82

5.3.4 Type 1 Diabetes 83

5.3.5 Other Localized Autoimmune Diseases 84

6 Segmentation of Global Market by Gender 85

6.1 Market Overview by Gender 85

6.2 Female Patients 87

6.3 Male Patients 88

7 Segmentation of Global Market by Age 89

7.1 Market Overview by Age 89

7.2 < 44 91

7.3 44 - 64 92

7.4 > 64 93

8 Segmentation of Global Market by End User 94

8.1 Market Overview by End User 94

8.2 Hospitals 96

8.3 Clinics 97

8.4 Diagnostic Labs 98

8.5 Other End Users 99

9 Segmentation of Global Market by Region 100

9.1 Geographic Market Overview 2021-2031 100

9.2 North America Market 2021-2031 by Country 104

9.2.1 Overview of North America Market 104

9.2.2 U.S. 108

9.2.3 Canada 111

9.2.4 Mexico 113

9.3 European Market 2021-2031 by Country 115

9.3.1 Overview of European Market 115

9.3.2 Germany 119

9.3.3 U.K. 121

9.3.4 France 123

9.3.5 Spain 125

9.3.6 Italy 127

9.3.7 Russia 129

9.3.8 Rest of European Market 131

9.4 Asia-Pacific Market 2021-2031 by Country 133

9.4.1 Overview of Asia-Pacific Market 133

9.4.2 Japan 137

9.4.3 China 140

9.4.4 Australia 142

9.4.5 India 144

9.4.6 South Korea 146

9.4.7 Rest of APAC Region 148

9.5 South America Market 2021-2031 by Country 150

9.5.1 Argentina 153

9.5.2 Brazil 155

9.5.3 Chile 157

9.5.4 Rest of South America Market 159

9.6 MEA Market 2021-2031 by Country 160

9.6.1 UAE 163

9.6.2 Saudi Arabia 165

9.6.3 South Africa 167

9.6.4 Other National Markets 169

10 Competitive Landscape 170

10.1 Overview of Key Vendors 170

10.2 New Product Launch, Partnership, Investment, and M&A 173

10.3 Company Profiles 174

Abbott Laboratories 174

Beckman Coulter, Inc. 176

Biomerieux SA 177

Bio-rad Laboratories Inc. 178

F. Hoffmann-la Roche Ltd. 179

Hemagen Diagnostics Inc. 180

Myriad Genetics Inc. 181

PerkinElmer Inc. (Euroimmun AG) 182

Quest Diagnostics Inc. 183

Siemens Healthineers Inc. 184

Thermo Fisher Scientific Inc. 185

Trinity Biotech PLC 186

Werfen Company (Inova Diagnostics Inc.) 187

RELATED REPORTS 188


List Of Figure

List of Figures:

Figure 1. Research Method Flow Chart 15

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18

Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20

Figure 4. Global Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 23

Figure 5. Impact of COVID-19 on Business 26

Figure 6. Primary Drivers and Impact Factors of Global Autoimmune Disease Diagnostics Market 28

Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31

Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 31

Figure 9. Primary Restraints and Impact Factors of Global Autoimmune Disease Diagnostics Market 33

Figure 10. Investment Opportunity Analysis 37

Figure 11. Porter's Fiver Forces Analysis of Global Autoimmune Disease Diagnostics Market 40

Figure 12. Breakdown of Global Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 46

Figure 13. Global Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 46

Figure 14. Global Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, USD mn 47

Figure 15. Global Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, USD mn 48

Figure 16. Breakdown of Global Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 50

Figure 17. Global Addressable Market Cap in 2022-2031 by Test Type, Value (USD mn) and Share (%) 50

Figure 18. Global Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, USD mn 51

Figure 19. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, USD mn 53

Figure 20. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, USD mn 54

Figure 21. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, USD mn 55

Figure 22. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, USD mn 56

Figure 23. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, USD mn 57

Figure 24. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, USD mn 58

Figure 25. Global Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, USD mn 59

Figure 26. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, USD mn 61

Figure 27. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, USD mn 62

Figure 28. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, USD mn 63

Figure 29. Global Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, USD mn 64

Figure 30. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, USD mn 66

Figure 31. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, USD mn 67

Figure 32. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, USD mn 68

Figure 33. Global Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, USD mn 69

Figure 34. Breakdown of Global Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 71

Figure 35. Global Addressable Market Cap in 2022-2031 by Disease Type, Value (USD mn) and Share (%) 71

Figure 36. Global Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, USD mn 72

Figure 37. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, USD mn 74

Figure 38. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, USD mn 75

Figure 39. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, USD mn 76

Figure 40. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, USD mn 77

Figure 41. Global Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, USD mn 78

Figure 42. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, USD mn 80

Figure 43. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, USD mn 81

Figure 44. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, USD mn 82

Figure 45. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, USD mn 83

Figure 46. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, USD mn 84

Figure 47. Breakdown of Global Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 86

Figure 48. Global Addressable Market Cap in 2022-2031 by Gender, Value (USD mn) and Share (%) 86

Figure 49. Global Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, USD mn 87

Figure 50. Global Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, USD mn 88

Figure 51. Breakdown of Global Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 90

Figure 52. Global Addressable Market Cap in 2022-2031 by Age, Value (USD mn) and Share (%) 90

Figure 53. Global Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, USD mn 91

Figure 54. Global Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, USD mn 92

Figure 55. Global Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, USD mn 93

Figure 56. Breakdown of Global Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 94

Figure 57. Global Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 95

Figure 58. Global Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, USD mn 96

Figure 59. Global Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, USD mn 97

Figure 60. Global Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, USD mn 98

Figure 61. Global Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 99

Figure 62. Global Market Snapshot by Region 100

Figure 63. Geographic Spread of Worldwide Autoimmune Disease Diagnostics Market, 2021-2031, % of Sales Revenue 101

Figure 64. Global Addressable Market Cap in 2022-2031 by Region, Value (USD mn) and Share (%) 102

Figure 65. North American Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 105

Figure 66. Breakdown of North America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 106

Figure 67. Contribution to North America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 107

Figure 68. U.S. Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 109

Figure 69. Canada Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 111

Figure 70. Autoimmune Disease Diagnostics Market in Mexico, 2021-2031, USD mn 113

Figure 71. European Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 116

Figure 72. Breakdown of European Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 117

Figure 73. Contribution to Europe 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 118

Figure 74. Autoimmune Disease Diagnostics Market in Germany, 2021-2031, USD mn 119

Figure 75. Autoimmune Disease Diagnostics Market in U.K., 2021-2031, USD mn 121

Figure 76. Autoimmune Disease Diagnostics Market in France, 2021-2031, USD mn 123

Figure 77. Autoimmune Disease Diagnostics Market in Spain, 2021-2031, USD mn 125

Figure 78. Autoimmune Disease Diagnostics Market in Italy, 2021-2031, USD mn 127

Figure 79. Autoimmune Disease Diagnostics Market in Russia, 2021-2031, USD mn 129

Figure 80. Autoimmune Disease Diagnostics Market in Rest of Europe, 2021-2031, USD mn 131

Figure 81. Asia-Pacific Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 134

Figure 82. Breakdown of APAC Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 134

Figure 83. Contribution to APAC 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 136

Figure 84. Autoimmune Disease Diagnostics Market in Japan, 2021-2031, USD mn 138

Figure 85. Autoimmune Disease Diagnostics Market in China, 2021-2031, USD mn 140

Figure 86. Autoimmune Disease Diagnostics Market in Australia, 2021-2031, USD mn 142

Figure 87. Autoimmune Disease Diagnostics Market in India, 2021-2031, USD mn 144

Figure 88. Autoimmune Disease Diagnostics Market in South Korea, 2021-2031, USD mn 146

Figure 89. Autoimmune Disease Diagnostics Market in Rest of APAC, 2021-2031, USD mn 148

Figure 90. South America Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 151

Figure 91. Breakdown of South America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 151

Figure 92. Contribution to South America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 152

Figure 93. Autoimmune Disease Diagnostics Market in Argentina, 2021-2031, USD mn 153

Figure 94. Autoimmune Disease Diagnostics Market in Brazil, 2021-2031, USD mn 155

Figure 95. Autoimmune Disease Diagnostics Market in Chile, 2021-2031, USD mn 157

Figure 96. Autoimmune Disease Diagnostics Market in Rest of South America, 2021-2031, USD mn 159

Figure 97. Autoimmune Disease Diagnostics Market in Middle East and Africa (MEA), 2021-2031, USD mn 161

Figure 98. Breakdown of MEA Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 161

Figure 99. Contribution to MEA 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 162

Figure 100. Autoimmune Disease Diagnostics Market in UAE, 2021-2031, USD mn 163

Figure 101. Autoimmune Disease Diagnostics Market in Saudi Arabia, 2021-2031, USD mn 165

Figure 102. Autoimmune Disease Diagnostics Market in South Africa, 2021-2031, USD mn 167

Figure 103. Growth Stage of Global Autoimmune Disease Diagnostics Industry over the Forecast Period 170


List Of Table

List of Tables:

Table 1. Snapshot of Global Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 21

Table 2. World Economic Outlook, 2021-2031 25

Table 3. World Health Spending by Region, USD bn, 2013-2020 32

Table 4. Main Product Trends and Market Opportunities in Global Autoimmune Disease Diagnostics Market 36

Table 5. Global Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 45

Table 6. Global Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, USD mn 49

Table 7. Global Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, USD mn 52

Table 8. Global Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, USD mn 60

Table 9. Global Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, USD mn 65

Table 10. Global Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 70

Table 11. Global Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, USD mn 73

Table 12. Global Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, USD mn 79

Table 13. Global Autoimmune Disease Diagnostics Market by Gender, 2021-2031, USD mn 85

Table 14. Global Autoimmune Disease Diagnostics Market by Age, 2021-2031, USD mn 89

Table 15. Global Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 94

Table 16. Global Autoimmune Disease Diagnostics Market by Region, 2021-2031, USD mn 101

Table 17. Leading National Autoimmune Disease Diagnostics Market, 2021 and 2031, USD mn 103

Table 18. North America Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 106

Table 19. U.S. Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 110

Table 20. U.S. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 110

Table 21. U.S. Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 110

Table 22. Canada Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 112

Table 23. Canada Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 112

Table 24. Canada Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 112

Table 25. Mexico Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 114

Table 26. Mexico Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 114

Table 27. Mexico Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 114

Table 28. Europe Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 118

Table 29. Germany Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 120

Table 30. Germany Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 120

Table 31. Germany Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 120

Table 32. U.K. Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 122

Table 33. U.K. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 122

Table 34. U.K. Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 122

Table 35. France Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 124

Table 36. France Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 124

Table 37. France Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 124

Table 38. Spain Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 126

Table 39. Spain Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 126

Table 40. Spain Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 126

Table 41. Italy Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 128

Table 42. Italy Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 128

Table 43. Italy Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 128

Table 44. Russia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 130

Table 45. Russia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 130

Table 46. Russia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 130

Table 47. Autoimmune Disease Diagnostics Market in Rest of Europe by Country, 2021-2031, USD mn 132

Table 48. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 135

Table 49. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 139

Table 50. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 139

Table 51. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 139

Table 52. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 141

Table 53. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 141

Table 54. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 141

Table 55. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 143

Table 56. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 143

Table 57. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 143

Table 58. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 145

Table 59. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 145

Table 60. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 145

Table 61. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 147

Table 62. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 147

Table 63. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 147

Table 64. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, USD mn 149

Table 65. South America Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 152

Table 66. Argentina Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 154

Table 67. Argentina Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 154

Table 68. Argentina Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 154

Table 69. Brazil Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 156

Table 70. Brazil Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 156

Table 71. Brazil Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 156

Table 72. Chile Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 158

Table 73. Chile Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 158

Table 74. Chile Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 158

Table 75. MEA Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 162

Table 76. UAE Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 164

Table 77. UAE Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 164

Table 78. UAE Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 164

Table 79. Saudi Arabia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 166

Table 80. Saudi Arabia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 166

Table 81. Saudi Arabia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 166

Table 82. South Africa Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 168

Table 83. South Africa Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 168

Table 84. South Africa Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 168

Table 85. Abbott Laboratories: Company Snapshot 174

Table 86. Abbott Laboratories: Business Segmentation 175

Table 87. Abbott Laboratories: Product Portfolio 175

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)